Mutant NPM1: Nuclear export and the mechanism of leukemogenesis

被引：5
|
作者：
Falini, Brunangelo [1 ,2 ,3 ,6 ]
Martelli, Maria Paola [1 ,2 ,3 ]
Brunetti, Lorenzo [4 ,5 ]
机构：
[1] Univ Perugia, Inst Hematol, Perugia, Italy
[2] Univ Perugia, Ctr Hematooncol Res CREO, Perugia, Italy
[3] Santa Maria Misericordia Hosp, Perugia, Italy
[4] Univ Politecn Marche, Dept Clin & Mol Sci, Ancona, Italy
[5] Osped Riuniti Marche, Dept Hematol, Ancona, Italy
[6] Univ Perugia, CREO, Perugia, Italy
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 04期
基金：
欧盟地平线“2020”;
关键词：
ACUTE MYELOID-LEUKEMIA; CYTOPLASMIC NUCLEOPHOSMIN;
D O I：
10.1002/ajh.26862
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：550 / 552
页数：3
相关论文
共 50 条
  • [21] A novel leukemic route of mutant NPM1 through nuclear import of the overexpressed long noncoding RNA LONA
    Gourvest, Morgane
    De Clara, Etienne
    Wu, Hsin-Chieh
    Touriol, Christian
    Meggetto, Fabienne
    De The, Hugues
    Pyronnet, Stephane
    Brousset, Pierre
    Bousquet, Marina
    LEUKEMIA, 2021, 35 (10) : 2784 - 2798
  • [22] Expression of a Dominant Negative Mutant of NPM1 in Neuroblastoma Cells Results in Altered Localization of NPM1.
    Mohiuddin, Saad
    Campbell, Jaclyn
    Keeler, Kelly
    Kristjansdottir, Kolla
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2018, 54 (07) : 540 - 540
  • [23] SELECTIVE SILENCING OF THE NPM1 MUTANT PROTEIN AND APOPTOSIS INDUCTION UPON ATRA IN VITRO TREATMENT OF AML CELLS CARRYING NPM1 MUTATIONS
    Martelli, M. P.
    Pettirossi, V.
    Manes, N.
    Susta, F.
    Orvietani, P. L.
    Liso, A.
    Mezzasoma, F.
    Cecchetti, F.
    De Marco, M. F.
    Bigerna, B.
    Pucciarini, A.
    Nicoletti, I.
    Binaglia, L.
    Mecucci, C.
    Martelli, M. F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 7 - 7
  • [24] A novel leukemic route of mutant NPM1 through nuclear import of the overexpressed long noncoding RNA LONA
    Morgane Gourvest
    Etienne De Clara
    Hsin-Chieh Wu
    Christian Touriol
    Fabienne Meggetto
    Hugues De Thé
    Stéphane Pyronnet
    Pierre Brousset
    Marina Bousquet
    Leukemia, 2021, 35 : 2784 - 2798
  • [25] Clinical and Molecular Characteristics of NPM1 MT De Novo AML ( NPM1 MT dnAML) Differ from NPM1 MT therapy-associated AML ( NPM1 MT tAML)
    Dhillon, Vikram
    Aguilar, Jeff
    Reddy, Sushmitha Nanja
    Potluri, Lakshmi Bhavani
    Dyson, Gregory
    Maciejewski, Jaroslaw P.
    Balasubramanian, Suresh Kumar
    BLOOD, 2023, 142
  • [26] NUCLEAR RELOCALIZATION OF MUTANT NPM1 INDUCES DOWNREGULATION OF HOX/MEIS1, TERMINAL DIFFERENTIATION, AND CELL CYCLE ARREST
    Gundry, Michael
    Brunetti, Lorenzo
    Sheppard, Hadley
    Guzman, Anna
    Goodell, Margaret
    EXPERIMENTAL HEMATOLOGY, 2017, 53 : S45 - S45
  • [27] Selective silencing of the NPM1 mutant protein and apoptosis induction upon ATRA in vitro treatment of AML cells carrying NPM1 mutations.
    Martelli, M. P.
    Pettirossi, V.
    Manes, N.
    Liso, A.
    Cecchetti, F.
    De Marco, M. F.
    Bigerna, B.
    Pucciarini, A.
    Nicoletti, I.
    Martelli, M. F.
    Falini, B.
    BLOOD, 2007, 110 (11) : 266A - 266A
  • [28] Mutant NPM1 Is Recruited to MLL Target Genes Via Its Acidic Stretch and Nuclear Export Factor CRM1 and Regulates Oncogenic Transcription in Acute Myeloid Leukemia
    Uckelmann, Hannah J.
    Haarer, Elena L.
    Takeda, Reina
    Wong, Eric
    Marinaccio, Christian
    Hatton, Charles
    Wen, Yanhe
    Perner, Florian
    Rajput, Masooma
    Antonissen, Noa J. C.
    Chen, Chun-Wei David
    Brunetti, Lorenzo
    Armstrong, Scott A.
    BLOOD, 2022, 140 : 5835 - 5836
  • [29] When the good go bad: Mutant NPM1 in acute myeloid leukemia
    Kunchala, Preethi
    Kuravi, Sudhakiranmayi
    Jensen, Roy
    McGuirk, Joseph
    Balusu, Ramesh
    BLOOD REVIEWS, 2018, 32 (03) : 167 - 183
  • [30] Mutant NPM1 predicts outcome in younger adults with AML and normal cytogenetics
    Carol Lovegrove
    Nature Clinical Practice Oncology, 2005, 2 (11): : 544 - 544
12345